OR WAIT 15 SECS
November 25, 2020
Tim Suther, senior vice president of data solutions at Change Healthcare, discusses a new Social Determinants of Health Analytics resource.
Lumasiran (Oxlumo; Alnylam Pharmaceuticals) is the first drug approved for the treatment of primary hyperoxaluria type 1, a rare genetic disorder.
November 11, 2020
SingleCare, in partnership with GeniusRx, launched the delivery service with the goal of improving access to and affordability of popular medications.
An overview of the use of satralizumab-mwge (Enspryng; Genentech) in neuromyelitis optica spectrum disorder (NMOSD).
October 28, 2020
Loteprednol etabonate ophthalmic suspension (Eysuvis; Kala Pharmaceuticals) 0.25% is the first ocular corticosteroid indicated for dry eye disease.
October 22, 2020
Remdesivir (Veklury; Gilead) is the first and only fully FDA-approved treatment for COVID-19.
October 16, 2020
Clascoterone cream 1% is a first-in-class topical acne treatment that targets the androgen receptors in the skin.
October 14, 2020
Oliceridine (Olinvyk; Trevena, Inc) is an intravenous opioid agonist indicated in adults for management of acute severe pain in a hospital or controlled clinical setting.
October 07, 2020
Apomorphine hydrochloride (Kynmobi; Sunovion) is a sublingual therapy for the acute intermittent treatment of off episodes in patients with Parkinson disease.
October 06, 2020
On June 25, 2020, fenfluramine (Fintepla) was approved for the treatment of seizures associated with Dravet syndrome in patients 2 years and older.
